Board of Directors

David P. Hochman

Chairman of the Board of Directors, Chief Executive Officer and Founder

Mr. Hochman has served as Chairman and Chief Executive Officer of Orchestra BioMed since May 2018. Since 2006, he has been Managing Partner of Orchestra Medical Ventures, LLC (“Orchestra Medical Ventures”), an investment firm that employs a strategy to create, build and invest in medical technology companies intended to generate substantial clinical value.

Jason Aryeh

Director

Mr. Aryeh became a member of Orchestra BioMed’s Board of Directors in November 2018. He previously served as a Strategic Advisor since July 2018.

Eric S. Fain, M.D.

Director

Dr. Fain became a member of Orchestra BioMed’s Board of Directors in November 2018. He previously served as a Strategic Advisor and a consultant to BackBeat Medical, Inc. since October 2017.

Darren R. Sherman

President, Chief Operating Officer and Director

Mr. Sherman has served as President, Chief Operating Officer and a member of the Board of Orchestra BioMed since May 2018. Since 2009, Mr. Sherman has been Managing Partner of Orchestra Medical Ventures, an investment firm that employs a strategy to create, build and invest in medical technology companies intended to generate substantial clinical value.

Geoffrey W. Smith

Director

Mr. Geoffrey Smith has been a member of the board of directors of Orchestra BioMed since May 2018. He previously served on the boards of directors of Caliber Therapeutics, Inc., BackBeat Medical, Inc., and FreeHold Surgical, Inc. He is a co-founder and General Partner of Ascent Biomedical Ventures, LLC (“Ascent”), a New York City-based venture capital firm focused on early-stage life sciences investments and an investor in Caliber, BackBeat and FreeHold.

Eric A. Rose, M.D.

Director

Dr. Rose became a member of Orchestra BioMed’s Board of Directors in December 2018. He previously served as a Strategic Advisor since July 2018.

Have any questions?
Contact us at 917.254.4900 or info@orchestrabiomed.com